|
시장보고서
상품코드
2084731
혈액 및 혈액 성분 시장 : 제품 유형별, 용도별, 최종사용자별, 지역별Blood and Blood Components Market, By Product Type, By Application, By End User, By Geography |
||||||
혈액 및 혈액 성분 시장 규모는 2026년에 513억 달러로 추계되고 있으며, 2033년까지 708억 달러에 달할 것으로 전망되고 있습니다. 2026-2033년에는 CAGR 4.7%로 성장할 것으로 예측됩니다.
| 리포트 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 513억 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년 예측 기간의 CAGR : | 4.70% | 2033년 시장 규모 예측 : | 708억 달러 |
혈액은 동맥, 정맥, 모세혈관 등의 혈관망을 통해 전신을 순환하는 특수한 체액입니다. 혈액은 적혈구, 백혈구, 혈장, 혈소판이라는 4가지 주요 성분으로 구성되어 있습니다. 적혈구(적혈구 또는 RBC라고도 함)는 혈액 세포의 대부분을 차지합니다. 적혈구에는 헤모글로빈이라고 불리는 특수한 붉은 색소가 포함되어 있으며, 폐에서 온 산소가 풍부한 혈액을 전신으로 운반하고, 산소를 소비한 혈액을 몸에서 폐로 운반하는 역할을 담당하고 있습니다. 적혈구의 평균 수명은 120일이며, 그 후 비장에 의해 제거됩니다. 백혈구(백혈구라고도 함)는 신체의 면역 체계를 구성하며, 미생물에 의한 감염증과 싸우는 역할을 합니다. 혈장은 혈액의 액체 성분으로, 물, 단백질, 당, 염류 및 지방이 혼합된 것입니다. 혈소판은 조직이 손상된 부위에서 혈액 응고를 돕습니다. 전혈은 45%가 혈액 세포, 55%가 혈장으로 구성되어 있습니다.
미국혈액학회(ASH)에 따르면 혈액은 인체 체중의 약 7-8%를 차지합니다. 혈액 및 그 성분은 외상으로 인한 출혈이나 출혈시 수혈, 암 치료 중 혈액량 유지, 그리고 출혈성 질환의 치료에 사용됩니다.
시장 역학
출혈성 질환 및 만성질환의 발생률 증가, 출혈성 질환 치료를 위한 신기술 개발을 목표로 한 연구개발 활동의 활성화, 그리고 시장에서 사업을 운영하는 주요 기업의 합병, 인수, 제휴, 공동 연구와 같은 비유기적 성장 전략의 확대가 예측 기간 중 전 세계 혈액 및 혈액 성분 시장의 성장을 촉진하는 주요 요인이 될 것으로 예상됩니다.
예를 들어 세계혈우병연맹(WFH)이 2018년에 발표한 통계에 따르면 2017년 기준으로 전 세계에서 40만 명 이상이 혈우병을 앓고 있었으며, 그중 약 17만 3,000명이 혈우병 A 또는 B로 진단받았습니다.
본 조사의 주요 특징
- 본 조사에서는 다양한 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한 본 조사에서는 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업이 채택하고 있는 경쟁 전략에 관한 중요 인사이트도 제공하고 있습니다.
- 본 조사에서는 다음의 매개변수를 바탕으로 전 세계 혈액 및 혈액 성분 시장의 주요 기업 개요을 작성하고 있습니다. 구체적으로는 기업 개요, 재무 실적, 제품 포트폴리오, 시장내 입지, 유통 전략, 주요 발전 사항, 전략 및 향후 계획입니다.
- 이 보고서를 통해 얻은 인사이트를 바탕으로, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 유형 업그레이드, 시장 확대 및 마케팅 전략에 대해 충분한 정보를 바탕으로 의사결정을 내릴 수 있게 됩니다.
- '세계의 혈액 및 혈액 성분 시장' 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자 여러분은 전 세계 혈액 및 혈액 성분 시장 분석에 활용되는 다양한 전략 매트릭스를 활용함으로써 의사결정을 원활하게 진행할 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 혈액 및 혈액 성분 시장 : 제품 유형별, 2021-2033년
제5장 세계의 혈액 및 혈액 성분 시장 : 용도별, 2021-2033년
제6장 세계의 혈액 및 혈액 성분 시장 : 최종사용자별, 2021-2033년
제7장 세계의 혈액 및 혈액 성분 시장 : 지역별, 2021-2033년
제8장 경쟁 구도
제9장 섹션
KSA 26.07.14Blood and Blood Components Market is estimated to be valued at USD 51.3 Bn in 2026 and is expected to reach USD 70.8 Bn by 2033, growing at a compound annual growth rate (CAGR) of 4.7% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 51.3 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 4.70% | 2033 Value Projection: | USD 70.8 Bn |
Blood is a specialized bodily fluid that circulates through the entire body with the help of a network of blood vessels such as arteries, veins, and capillaries. Blood is made up of four major components, which include red blood cells, white blood cells, plasma, and platelets. Red blood cells, also known as erythrocytes or RBC account for the major portion of blood cells. RBC have a specialized red colored pigment called hemoglobin, which is responsible for carrying oxygen rich blood from the lungs to the rest of the body and deoxygenated blood from the body to the lungs. The average life cycle of RBC is 120 days after which they are removed by the spleen. White blood cells, also known as leukocytes are responsible for making the immune system of the body and help fight against microbial infections. Plasma is the liquid component of blood and is a mixture of water, protein, sugar, salts, and fat. Platelets, also known as thrombocytes help in clotting of blood at the site of tissue injury. Whole blood consists of 45% blood cells and 55% plasma.
According to the American Society of Hematology, blood makes up around 7 to 8% of human body weight. Blood and blood components are used for blood transfusion in case of blood loss during a traumatic injury, hemorrhage to maintain blood volume during cancer treatment, and to treat bleeding disorders.
Market Dynamics
The increasing incidence of bleeding disorders and chronic diseases, rising research and development activities for the development of novel technology for the treatment of bleeding disorders, and increasing adoption of inorganic growth strategies such as mergers, acquisitions, partnerships, and collaborations by key players operating in the market are the major factors that are expected to drive growth of the global blood and blood components market over the forecast period.
For instance, according to the statistics provided by the World Federation of Hemophilia (WFH) in 2018, over 400,000 people suffered from hemophilia of which around 173,000 people were diagnosed with hemophilia A or B in 2017, across the globe.
Key features of the study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global blood and blood components market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
- Key companies covered as a part of this study include Becton, Dickinson & Co., Kidde-Fenwal Inc., Bio-Rad Laboratories, Inc., Cerus Corporation, Immucor, Beckman Coulter, Inc., bioMerieux SA, Octapharma AG, Abbott, CSL Behring LLC, MacoPharma, Shanghai RAAS, China Biologic Products Holdings, Inc., Takeda Pharmaceutical Company Limited, Grifols S.A., Bharat Serums and Vaccines Ltd., and Terumo BCT Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global blood and blood components market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global blood and blood components market
Market Segmentation
- By Product Type (Revenue, USD Bn, 2021-2033)
- Whole Blood
- Blood Components
- Red Blood Cells
- White Blood Cells
- Platelet
- Plasma
- By Application (Revenue, USD Bn, 2021-2033)
- Anemia
- Trauma and Surgery
- Cancer Treatment
- Bleeding Disorders
- Others (Others include rare blood diseases)
- By End User (Revenue, USD Bn, 2021-2033)
- Hospitals
- Ambulatory Surgical Centers
- Blood and Blood Component Bank
- Others
- By Region (Revenue, USD Bn, 2021-2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
- Key Players
- Becton, Dickinson & Co.
- Kidde-Fenwal Inc.
- Bio-Rad Laboratories, Inc.
- Cerus Corporation
- Immucor
- Beckman Coulter, Inc.
- bioMerieux SA
- Octapharma AG
- Abbott
- CSL Behring LLC
- MacoPharma
- Shanghai RAAS
- China Biologic Products Holdings, Inc.
- Takeda Pharmaceutical Company Limited
- Grifols S.A.
- Bharat Serums and Vaccines Ltd.
- Terumo BCT Inc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Product Approval
- Collaboration/Merge/Acquisition
- Regulatory Landscape
- PEST Analysis
- Porter's Five Forces Analysis
- Epidemiology
- Robust Pipeline Analysis
4. Global Blood and Blood Components Market, By Product Type, 2021 - 2033, (USD Billion)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
- Whole Blood
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
- Blood Components
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
- Red Blood Cells
- White Blood Cells
- Platelet
- Plasma
5. Global Blood and Blood Components Market, By Application, 2021 - 2033, (USD Billion)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Anemia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
- Trauma and Surgery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
- Cancer Treatment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
- Bleeding Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
- Others (Others include rare blood diseases)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
6. Global Blood and Blood Components Market, By End User, 2021 - 2033, (USD Billion)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospital
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
- Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
- Blood and Blood Component Bank
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
7. Global Blood and Blood Components Market, By Region, 2021 - 2033, (USD Billion)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022-2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
- Company Profile
- Becton, Dickinson & Co.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Kidde-Fenwal Inc.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Bio-Rad Laboratories, Inc.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Cerus Corporation
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Immucor
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Beckman Coulter, Inc.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- bioMerieux SA
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Octapharma AG
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Abbott, CSL Behring LLC
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- MacoPharma
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Shanghai RAAS
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- China Biologic Products Holdings, Inc.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Takeda Pharmaceutical Company Limited
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Grifols S.A.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Bharat Serums and Vaccines Ltd.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Terumo BCT Inc.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Becton, Dickinson & Co.
- Analyst Views
9. Section
- References
- Research Methodology
- About Us
